Risk of major congenital malformations and heart defects in pregnancies exposed to first-trimester drugs for depression and co-medications

This study provides exploratory insights into how first-trimester use of drugs for depression, alone or with selected co-medications, may relate to MCM and CHD patterns. These findings suggest potential interactions but could also result from confounding or chance. Further research is needed to support clinical decision-making.